US19459J1043
US19459J1043
Collegium Pharmaceutical, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 719.15M EUR | 1.18B EUR | 1.07B EUR | 1.47B EUR |
Enterprise Value | 1.81B EUR | 2.14B EUR | 1.61B EUR | 2.05B EUR |
Valuation Multiples | ||||
Trailing P/E | 17.39x | 24.55x | 14.3x | 24.28x |
Forward P/E | 3.33x | -- | -- | -- |
Price to Sales | 0.89x | 1.46x | 1.35x | 2.44x |
Price to Book | 2.3x | 3.77x | 3.43x | 4.87x |
EV/Revenue | 2.24x | 2.65x | 2.02x | 3.4x |
EV/EBITDA | 4.46x | 5.31x | 3.78x | 6.1x |
Price to FCF (P/FCF) | 2.22x | 3.58x | 3.25x | 5.38x |
EV/FCF | 5.58x | 6.53x | 4.88x | 7.52x |
FCF Yield | 45.06% | 27.9% | 30.78% | 18.59% |